Purchase Order 75A50121P00031
- Not listed
- The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $820,000 firm fixed price purchase order to Diasorin Inc. to deliver DIASORIN SARS-COV-2 TRIMERICS IGG ASSAY & 501(K) VALIDATION. The contract supports the agency's efforts to address the Coronavirus COVID-19 national interest through validation and delivery of Diasorin's SARS-CoV-2 antibody test. Performance will occur in Stillwater, Minnesota through March 2022. No set...
- This is a $236,090 firm-fixed-price federal contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Diasorin Inc., a foreign-owned for-profit organization. The contract is for the provision of Diasorin's LIAISON SARS-COV-2 S1/S2 IgG diagnostic testing products and services, including analyzers, reagents, test kits, controls, training, maintenance, and technical support. The contract is not designated as a set-aside. It...
- Diasorin Molecular LLC was awarded a $4.04 million firm fixed price purchase order by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to provide COVID-19 laboratory diagnostics using their PCR Simplexa Direct assays, which have 510(k) clearance from the Food and Drug Administration. The diagnostics will be delivered from Diasorin Molecular LLC's facility in Cypress, California over a period of approximately 18 months ending in September...
- The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded Siemens Healthcare Diagnostics Inc. a $13 million firm fixed price purchase order to develop SARS-CoV-2 antigen tests for the Advia Centaur and Atellica IM systems. As the prime contractor, Siemens Healthcare Diagnostics will deliver coronavirus COVID-19 testing capabilities to support the agency's response efforts. The tests will be developed and the contract performed in Norwood,...
- This contract award was made by the Department of the Air Force Materiel Command Lifecycle Management Center to Diasorin Inc., a for-profit foreign-owned company that specializes in diagnostic testing equipment and assays. The $199,230.00 firm-fixed-price purchase order is for the provision of COVID-19 reagents. Diasorin has previously supported federal healthcare agencies such as the Department of Veterans Affairs (VA), Department of Defense (DoD), and Department of Health and Human Services...
- This is a $249,000 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Diasorin Inc., a foreign-owned for-profit company, for its "SCIENCE TEAM" requirement. The contract has an ultimate completion date of September 28, 2024. Diasorin Inc. is a manufacturer of fully automated diagnostic testing equipment, assays, reagents, and related services for the medical industry. It has a proven track record as a federal contractor,...
- This definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response is valued at $697,423 to Diasorin Molecular LLC for the development of the Simplexa COVID-19 Direct Assay. The contract was awarded under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002, which sought host-directed therapeutic candidates to aid long-term outcomes from lung injury. Diasorin Molecular LLC will develop...
- Siemens Healthcare Diagnostics Inc. was awarded an $11.95 million firm fixed price purchase order by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to develop the SARS-CoV-2 Antigen (CoV2Ag) test for the Advia Centaur and Atellica IM diagnostic platforms. The contract aims to support the government's response to the Coronavirus Disease 2019 pandemic by facilitating testing capabilities. As the prime contractor, Siemens Healthcare...
- This firm-fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Diasorin Molecular LLC, a foreign-owned for-profit manufacturer of medical diagnostic products and testing equipment. The contract, valued at $337,734.52, is to provide COVID-19 molecular diagnostic tests, reagents, and laboratory instrumentation to support infectious disease testing and surveillance at VA hospitals and clinics across various Veterans Integrated Service...
- This federal contract award for $350,000 was issued by the Defense Health Agency (DHA) to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company. The contract is for the provision of reagents and closely associated functions, with an ultimate completion date of September 30, 2017. This award is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type. Diasorin Inc. is a subsidiary of the Italian-based Diasorin S.P.A. and has a significant presence in the U.S....
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $1.8 million firm fixed price purchase order to Diasorin S.P.A. of Italy to develop, validate, manufacture, market, and obtain regulatory authorization for a nucleocapsid antigen of SARS-CoV-2. The contract is being funded through the Coronavirus COVID-19 National Interest Action Code and will support efforts to address the ongoing COVID-19 pandemic. Work will be performed in Italy over an one-year period ending in March 2022. No subcontractors or set aside designations were identified. This purchase order leverages the expertise of Diasorin S.P.A to help combat COVID-19 through the development and authorization of antigen tests, in alignment with HHS's role in biodefense and emergency preparedness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Change Order | ($370k) | 3/17/22 | |
| Not listed | Not listed | $2.2m | 3/19/21 |